Investor Relations

NYSE: TDOC -0.01 -0.19%
Volume: 3,494,684
20 minute delay April 2, 2026

Teladoc Health is the global leader in virtual care.

We are transforming how better health happens.

Teladoc Health is delivering and orchestrating care across patients, care providers, platforms, and partners for more complete and personalized care. Through our technology, services and clinical expertise, we equip care teams to perform at their highest caliber and address comprehensive health needs – physical and mental, simple and complex, urgent and ongoing. By applying the power of technology and insights, we elevate care experiences and make moments of care more impactful. We work with health plans, employers, health systems, and partners around the world to unlock access and outcomes at unmatched scale, helping millions of people live their healthiest lives.

Investor Events

Investor News

March 30, 2026
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) - Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board’s audit and compensation committees. “Susan brings a powerful combination of healthcare leadership and governance experience to the Board,” said Kenneth H. Paulus, non‑executive Chairman of the Teladoc Health board. “We will benefit from her insights on care delivery transformation as the company drives health outcomes at scale and creates durable value.” During her 33-year tenure at AMN Healthcare, Ms. Salka was one of the driving forces behind the company's...
Read More
March 4, 2026
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 57,034 shares of Common Stock (for which up to 114,068 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The performance stock units provide a target number of shares of Common Stock that would be earned over three years based on various financial metrics. The award was approved...
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Michael Minchak | Vice President, Investor Relations | IR@teladochealth.com